Exploring the pharmacogenomics knowledge base (pharmgkb) for repositioning breast cancer drugs by leveraging Web ontology language (owl) and cheminformatics approaches

Pacific Symposium on Biocomputing

Volumn , Issue , 2014, Pages 172-182

  Zhu, Qian ^a   Tao, Cui ^b   Shen, Feichen ^c   Chute, Christopher G ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; KNOWLEDGE BASED SYSTEMS; KNOWLEDGE MANAGEMENT; ONTOLOGY;

ADVERSE EFFECTS PREDICTIONS; COMPUTATIONAL TECHNOLOGY; DRUG REPOSITIONING; PHARMACOGENOMICS; SEMANTIC INFERENCE; SEMANTIC WEB TECHNOLOGY; US FOOD AND DRUG ADMINISTRATION; WEB ONTOLOGY LANGUAGE;

SEMANTIC WEB;

ANTINEOPLASTIC AGENT;

ARTICLE; BIOLOGY; BREAST TUMOR; CHEMISTRY; COMPUTER LANGUAGE; DRUG REPOSITIONING; FEMALE; GENETICS; HUMAN; INTERNET; KNOWLEDGE BASE; PHARMACOGENETICS; STATISTICS;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMPUTATIONAL BIOLOGY; DRUG REPOSITIONING; FEMALE; HUMANS; INTERNET; KNOWLEDGE BASES; PHARMACOGENETICS; PROGRAMMING LANGUAGES;

EID: 84905886868     PISSN: 23356928     EISSN: 23356936     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Ye, H., et al., A pathway profile-based method for drug repositioning. Chinese Science Bulletin, 2012.57(17): p. 2106-2112.
2. Napolitano, F., et al., Drug Repositioning: A Machine-Learning Approach through Data Integration. Journal of Cheminformatics, 2013.5(1): p. 30.
3. Li, J. and Z. Lu. A new method for computational drug repositioning using drug pairwise similarity. in Bioinformatics and Biomedicine (BIBM), 2012 IEEE International Conference on. 2012: IEEE.
4. Dudley, J. T., et al., Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease. Science Translational Medicine, 2011.3(96): p. 96ra76.
5. Sirota, M., et al., Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data. Science Translational Medicine, 2011.3(96): p. 96ra77.
6. Pathak, J., R. C. Kiefer, and C. G. Chute, Using Semantic Web Technologies for Cohort Identification from Electronic Health Records for Clinical Research. AMIA Summits on Translational Science Proceedings, 2012. 2012: p. 10.
7. Searls, D. B., Data integration: challenges for drug discovery. Nature Reviews Drug Discovery, 2005.4(1): p. 45-58.
8. Olsson, T. and T. I. Oprea, Cheminformatics: a tool for decision-makers in drug discovery. Current opinion in drug discovery & development, 2001.4(3): p. 308.
9. Hewett, M., et al., PharmGKB: the pharmacogenetics knowledge base. Nucleic acids research, 2002.30(1): p. 163-165.
10. Dumontier, M. and N. Villanueva-Rosales, Towards pharmacogenomics knowledge discovery with the semantic web. Briefings in Bioinformatics, 2009.
11. Drugs Approved for Breast Cancer. [cited 2013 July 3rd]; Available from: http://www.cancer.gov/cancertopics/druginfo/breastcancer.
12. Resource Description Framework (RDF). [cited 2013 July 17th]; Available from: http://www.w3.org/RDF/.
13. OWL Web Ontology Language. [cited 2013 July 17th]; Available from: http://www.w3.org/TR/owl-features/.
14. An Executive Intro to Ontologies. 2009; Available from: http://www.mkbergman. com/900/an-executive-intro-to-ontologies/.
15. Simplified molecular-input line-entry system (SMILES). [cited 2013 July 3rd]; Available from: http://en. wikipedia.org/wiki/Simplified-molecular-input-line-entry-system.
16. The IUPAC International Chemical Identifier (InChI). [cited 2013 July 3rd]; Available from: http://www.iupac.org/home/publications/e-resources/inchi.html.
17. PubChem Entrez Programming Utilities. [cited 2013 July 3rd]; Available from: http://www.ncbi.nlm.nih.gov/books/NBK25500/.
18. NCI Chemical Identifier Resolver. [cited 2013 July 3rd]; Available from: http://cactus.nci.nih.gov/chemical/structure.
19. Butina, D., Unsupervised data base clustering based on daylight's fingerprint and Tanimoto similarity: A fast and automated way to cluster small and large data sets. Journal of Chemical Information and Computer Sciences, 1999.39(4): p. 747-750.
20. Steinbeck, C., et al., The Chemistry Development Kit (CDK): An open-source Java library for chemo- and bioinformatics. Journal of Chemical Information and Computer Sciences, 2003.43(2): p. 493-500.
21. Protégé. [cited 2013 July 3rd]; Available from: http://protege.stanford.edu/.
22. Baader, F. 2003: Cambridge university press.
23. Tamoxifen. [cited 2013 July 3rd]; Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0012290/?report=details.
24. Lee, J.-Y., et al., Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells. Oncology reports, 2012.27(1): p. 87-93.
25. Clinical Trail for Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer. [cited 2013 July 3rd]; Available from: http://clinicaltrials.gov/ct2/show/record/NCT00041080.
26. Clomiphene [cited 2013 July 3rd]; Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0009673/?report=details.
27. Dhaliwal, L. K., et al., Tamoxifen: An alternative to clomiphene in women with polycystic ovary syndrome. Journal of human reproductive sciences, 2011.4(2): p. 76.
28. Tamoxifen citrate and Rheumatoid arthritis. [cited 2013 July 3rd]; Available from: http://www.ehealthme.com/ds/tamoxifen+citrate/rheumatoid+arthritis.